1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Optipharm.CO.,LTD
  6. Summary
    A153710   KR7153710009

OPTIPHARM.CO.,LTD

(A153710)
  Report
End-of-day quote. End-of-day quote Korea Stock Exchange - 05/27
9480 KRW   +1.61%
2020OPTIPHARM.CO.,LTD(KOSDAQ : A153710) added to S&P Global BMI Index
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
05/23/2022 05/24/2022 05/25/2022 05/26/2022 05/27/2022 Date
9240 9760 9340 9330 9480 Last
43045 238573 258887 31318 127088 Volume
-2.43% +5.63% -4.30% -0.11% +1.61% Change
Estimated financial data (e)
Sales 2020 13 046 M 10,4 M 10,4 M
Net income 2020 -2 352 M -1,88 M -1,88 M
Net cash position 2020 17 688 M 14,1 M 14,1 M
P/E ratio 2020 -93,3x
Yield 2020 -
Sales 2021 14 258 M 11,4 M 11,4 M
Net income 2021 -3 080 M -2,46 M -2,46 M
Net cash position 2021 16 126 M 12,9 M 12,9 M
P/E ratio 2021 -44,4x
Yield 2021 -
Capitalization 139 B 111 M 111 M
EV / Sales 2020 15,5x
EV / Sales 2021 8,50x
Nbr of Employees -
Free-Float 58,6%
More Financials
Company
Optipharm.CO.,LTD is a Korea-based company mainly engaged in the production and sale of veterinary drugs. The Company operates its business through two segments. The Sale Business segment is involved in the provision of livestock disease appraisal services, animal drug distribution, and the manufacturing and sale of feed additives. The New Business segment is engaged in research and development of heterologous... 
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
More about the company
All news about OPTIPHARM.CO.,LTD
2020OPTIPHARM.CO.,LTD(KOSDAQ : A153710) added to S&P Global BMI Index
CI
More news
News in other languages on OPTIPHARM.CO.,LTD

- No features available -

More news
Chart OPTIPHARM.CO.,LTD
Duration : Period :
Optipharm.CO.,LTD Technical Analysis Chart | A153710 | KR7153710009 | MarketScreener
Technical analysis trends OPTIPHARM.CO.,LTD
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Managers and Directors
Hyun-Il Kim Chief Executive Officer & Director
Ki-Myung Choi Director & Head-Development
Young-Ho Kim Independent Director
Jae-Wan Park Independent Director
Hyeon-Wuk Choi Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPTIPHARM.CO.,LTD0.74%111
ZOETIS-29.48%80 995
ELANCO ANIMAL HEALTH INCORPORATED-15.89%11 317
DECHRA PHARMACEUTICALS PLC-32.21%4 936
BLUESTAR ADISSEO COMPANY-23.21%3 787
VIRBAC-11.07%3 416